Get started
Author

Eric D. Jong

Observed name: Eric Jong
Observed institutions: University of New Brunswick, St. Michael's Hospital, University of Toronto, Lunenfeld-Tanenbaum Research Institute, The Francis Crick Institute, Sinai Health System
ORCID: 0000-0003-1117-9555
Observed ORCID: 0000-0003-1117-9555
OpenAlex ID: A5004575297
Immune-privileged tissues formed from immunologically cloaked mouse embryonic stem cells survive long term in allogeneic hosts
2023 · Jeffrey Harding, Kristina Vintersten-Nagy, et al. · Nature Biomedical Engineering · 52
PDF
Jack of many trades: Multifaceted role of neuropilins in pancreatic cancer
2018 · Pratiek N. Matkar, Eric D. Jong, et al. · Cancer Medicine · 34
PDF
A Model-System to Address the Impact of Phenotypic Heterogeneity and Plasticity on the Development of Cancer Therapies
2019 · Eric D. Jong, Irina C. W. Chan, et al. · Frontiers in Oncology · 11
PDF
Human TET2 -Mutant Clonal Hematopoiesis Expansion Is Driven by Distinct Inflammatory Signaling Responses in Stem Cells Versus Myeloid Progeny
2025 · Hector Huerga Encabo, Giuseppe D’Agostino, et al. · Blood Cancer Discovery · 9
Cryotherapy: not as cool as it seems
2018 · Shamara Nadarajah, Ramya Ariyagunarajah, et al. · The Journal of Physiology · 7
PDF
Soluble CX3CL1-expressing retinal pigment epithelium cells protect rod photoreceptors in a mouse model of retinitis pigmentosa
2023 · Eric D. Jong, Sabiha Hacibekiroglu, et al. · Stem Cell Research & Therapy · 6
PDF
Data from Human TET2-Mutant Clonal Hematopoiesis Expansion Is Driven by Distinct Inflammatory Signaling Responses in Stem Cells Versus Myeloid Progeny
2026 · Hector Huerga Encabo, Giuseppe D’Agostino, et al. · 3
Cell-based passive immunization for protection against SARS-CoV-2 infection
2023 · Evan Sawula, Shane Miersch, et al. · Stem Cell Research & Therapy · 3
PDF
Genome-edited safe and immune-evasive human pluripotent cells: Potential solution for allogeneic therapies
2026 · Vivian Tam, Nicole Ching Man Wong, et al. · Stem Cell Reports · 1
Supplementary Table S5 from Human TET2-Mutant Clonal Hematopoiesis Expansion Is Driven by Distinct Inflammatory Signaling Responses in Stem Cells Versus Myeloid Progeny
2026 · Hector Huerga Encabo, Giuseppe D’Agostino, et al.
Supplementary Table S4 from Human TET2-Mutant Clonal Hematopoiesis Expansion Is Driven by Distinct Inflammatory Signaling Responses in Stem Cells Versus Myeloid Progeny
2026 · Hector Huerga Encabo, Giuseppe D’Agostino, et al.
Supplementary Table S1 from Human TET2-Mutant Clonal Hematopoiesis Expansion Is Driven by Distinct Inflammatory Signaling Responses in Stem Cells Versus Myeloid Progeny
2026 · Hector Huerga Encabo, Giuseppe D’Agostino, et al.
Supplementary Figures S1-S7 from Human TET2-Mutant Clonal Hematopoiesis Expansion Is Driven by Distinct Inflammatory Signaling Responses in Stem Cells Versus Myeloid Progeny
2026 · Hector Huerga Encabo, Giuseppe D’Agostino, et al.
Supplementary Table S2 from Human TET2-Mutant Clonal Hematopoiesis Expansion Is Driven by Distinct Inflammatory Signaling Responses in Stem Cells Versus Myeloid Progeny
2026 · Hector Huerga Encabo, Giuseppe D’Agostino, et al.
Supplementary Table S6 from Human TET2-Mutant Clonal Hematopoiesis Expansion Is Driven by Distinct Inflammatory Signaling Responses in Stem Cells Versus Myeloid Progeny
2026 · Hector Huerga Encabo, Giuseppe D’Agostino, et al.
Supplementary Table S7 from Human TET2-Mutant Clonal Hematopoiesis Expansion Is Driven by Distinct Inflammatory Signaling Responses in Stem Cells Versus Myeloid Progeny
2026 · Hector Huerga Encabo, Giuseppe D’Agostino, et al.
Supplementary Table S3 from Human TET2-Mutant Clonal Hematopoiesis Expansion Is Driven by Distinct Inflammatory Signaling Responses in Stem Cells Versus Myeloid Progeny
2026 · Hector Huerga Encabo, Giuseppe D’Agostino, et al.
Passive heat therapy: the next hot thing for cardiovascular health!
2016 · Daniel Lazzam, Bridget Wang, et al. · The Journal of Physiology
Works count: 18
Citation count: 126
H-index: 6
I10-index: 3
Year
Topic
Type